Literature DB >> 19364636

Decision analysis to complete diagnostic research by closing the gap between test characteristics and cost-effectiveness.

Joanna D Schaafsma1, Yolanda van der Graaf, Gabriel J E Rinkel, Erik Buskens.   

Abstract

OBJECTIVE: The lack of a standard methodology in diagnostic research impedes adequate evaluation before implementation of constantly developing diagnostic techniques. We discuss the methodology of diagnostic research and underscore the relevance of decision analysis in the process of evaluation of diagnostic tests. STUDY DESIGN AND
SETTING: Overview and conceptual discussion.
RESULTS: Diagnostic research requires a stepwise approach comprising assessment of test characteristics followed by evaluation of added value, clinical outcome, and cost-effectiveness. These multiple goals are generally incompatible with a randomized design. Decision-analytic models provide an important alternative through integration of the best available evidence. Thus, critical assessment of clinical value and efficient use of resources can be achieved.
CONCLUSION: Decision-analytic models should be considered part of the standard methodology in diagnostic research. They can serve as a valid alternative to diagnostic randomized clinical trials (RCTs).

Mesh:

Year:  2009        PMID: 19364636     DOI: 10.1016/j.jclinepi.2009.01.008

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  18 in total

1.  Added value of cost-utility analysis in simple diagnostic studies of accuracy: (18)F-fluoromethylcholine PET/CT in prostate cancer staging.

Authors:  Oke Gerke; Mads H Poulsen; Poul Flemming Høilund-Carlsen
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-01-15

Review 2.  Toward a Framework for Outcome-Based Analytical Performance Specifications: A Methodology Review of Indirect Methods for Evaluating the Impact of Measurement Uncertainty on Clinical Outcomes.

Authors:  Alison F Smith; Bethany Shinkins; Peter S Hall; Claire T Hulme; Mike P Messenger
Journal:  Clin Chem       Date:  2019-08-23       Impact factor: 8.327

3.  Long-term risk of aneurysmal subarachnoid hemorrhage after a negative aneurysm screen.

Authors:  Ingeborg Rasing; Ynte M Ruigrok; Paut Greebe; Birgitta K Velthuis; Theo D Witkamp; Marieke J H Wermer; Yvo B Roos; W Peter Vandertop; Gabriel J E Rinkel
Journal:  Neurology       Date:  2015-01-30       Impact factor: 9.910

4.  Demonstrating the benefits of clinical nuclear imaging: is it time to add economic analysis?

Authors:  Poul F Høilund-Carlsen; Oke Gerke; Werner Vach
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-09       Impact factor: 9.236

Review 5.  Methodologic approaches to evaluating new highly sensitive diagnostic tests: avoiding overdiagnosis.

Authors:  Joris A H de Groot; Christiana A Naaktgeboren; Johannes B Reitsma; Karel G M Moons
Journal:  CMAJ       Date:  2016-07-04       Impact factor: 8.262

6.  Gathering and learning from relevant clinical data: a new framework.

Authors:  Michael Farias; Kevin G Friedman; James E Lock; Rahul H Rathod
Journal:  Acad Med       Date:  2015-02       Impact factor: 6.893

Review 7.  Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Authors:  Piotr Lewczuk; Peter Riederer; Sid E O'Bryant; Marcel M Verbeek; Bruno Dubois; Pieter Jelle Visser; Kurt A Jellinger; Sebastiaan Engelborghs; Alfredo Ramirez; Lucilla Parnetti; Clifford R Jack; Charlotte E Teunissen; Harald Hampel; Alberto Lleó; Frank Jessen; Lidia Glodzik; Mony J de Leon; Anne M Fagan; José Luis Molinuevo; Willemijn J Jansen; Bengt Winblad; Leslie M Shaw; Ulf Andreasson; Markus Otto; Brit Mollenhauer; Jens Wiltfang; Martin R Turner; Inga Zerr; Ron Handels; Alexander G Thompson; Gunilla Johansson; Natalia Ermann; John Q Trojanowski; Ilker Karaca; Holger Wagner; Patrick Oeckl; Linda van Waalwijk van Doorn; Maria Bjerke; Dimitrios Kapogiannis; H Bea Kuiperij; Lucia Farotti; Yi Li; Brian A Gordon; Stéphane Epelbaum; Stephanie J B Vos; Catharina J M Klijn; William E Van Nostrand; Carolina Minguillon; Matthias Schmitz; Carla Gallo; Andrea Lopez Mato; Florence Thibaut; Simone Lista; Daniel Alcolea; Henrik Zetterberg; Kaj Blennow; Johannes Kornhuber
Journal:  World J Biol Psychiatry       Date:  2017-10-27       Impact factor: 4.132

8.  A cost-effectiveness analysis of screening for intracranial aneurysms in persons with one first-degree relative with subarachnoid haemorrhage.

Authors:  Esther M Hopmans; Ynte M Ruigrok; Anne Se Bor; Gabriel Je Rinkel; Hendrik Koffijberg
Journal:  Eur Stroke J       Date:  2016-10-19

9.  Diagnostic and economic evaluation of new biomarkers for Alzheimer's disease: the research protocol of a prospective cohort study.

Authors:  Ron L H Handels; Pauline Aalten; Claire A G Wolfs; Marcel OldeRikkert; Philip Scheltens; Pieter Jelle Visser; Manuela A Joore; Johan L Severens; Frans R J Verhey
Journal:  BMC Neurol       Date:  2012-08-10       Impact factor: 2.474

Review 10.  Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis.

Authors:  Henrike J Schouten; G J Geersing; H L Koek; Nicolaas P A Zuithoff; Kristel J M Janssen; Renée A Douma; Johannes J M van Delden; Karel G M Moons; Johannes B Reitsma
Journal:  BMJ       Date:  2013-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.